- Home
- ORKA vs UAN Comparison
ORKA vs UAN Comparison
Compare ORKA & UAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORKA | UAN |
|---|---|---|
| Founded | 2004 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.3B |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | ORKA | UAN |
|---|---|---|
| Price | $57.54 | $121.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $92.50 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 44.5K |
| Earning Date | 05-13-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 7.91% |
| EPS Growth | N/A | ★ 61.98 |
| EPS | N/A | ★ 4.72 |
| Revenue | N/A | ★ $606,038,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $25.95 |
| Revenue Growth | N/A | ★ 15.36 |
| 52 Week Low | $10.97 | $81.18 |
| 52 Week High | $91.00 | $139.50 |
Technical Indicators
Market Signals| Indicator | ORKA | UAN |
|---|---|---|
| Relative Strength Index (RSI) | 43.51 | 41.35 |
| Support Level | $54.99 | $120.05 |
| Resistance Level | $91.00 | $139.42 |
| Average True Range (ATR) | 3.14 | 4.59 |
| MACD | -0.95 | -0.88 |
| Stochastic Oscillator | 23.40 | 5.14 |
Price Performance
Historical ComparisonAbout ORKA Oruka Therapeutics Inc.
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.
About UAN CVR Partners LP
CVR Partners LP is a manufacturer and supplier of nitrogen fertilizer products. Its principal products include Urea Ammonium Nitrate (UAN) and ammonia. The company market ammonia products to industrial and agricultural customers and UAN products to agricultural customers. The primary geographic markets for its fertilizer products are Kansas, Missouri, Nebraska, Iowa, Illinois, Colorado, and Texas. The company's product sales are heavily weighted toward UAN.